RenBio, Inc. — Form D
RenBio, Inc. of Long Island City, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-19. The offering totals $24.0M, of which $14.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-01-19
- Form: D
- Accession: 0001567619-21-001127
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.0M
- Amount sold: $14.0M
- Remaining: $10.0M
- Investors: 7
- Date of first sale: 2020-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-386614
Issuer
- Name: RenBio, Inc.
- CIK: 0001840723
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 30-02 48th Avenue, Long Island City, NY, 11101
- Phone: (646) 440-9411
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Chi-Chuan Chen | Director | New York, NY |
| David Chu | Director | New York, NY |
| Neal Padte | Director | New York, NY |
| Wan Feng Ting | Director | New York, NY |
| Tamon Tseng | Director | New York, NY |
| Neal Padte | Executive Officer | New York, NY |
| Jaap A Goudsmit, M.D., Ph.D. | Director | Long Island City, NY |
| Rachel A Liberatore, Ph.D. | Director | Long Island City, NY |
| Rachel A Liberatore, Ph.D. | Executive Officer | Long Island City, NY |
| Zhi A Hong, Ph.D. | Director | Long Island City, NY |
| Donald A Tang | Director | Long Island City, NY |
| Annelyn A O'Rourke | Executive Officer | Long Island City, NY |
| Walter A Wang, Sr. | Director | Long Island City, NY |
Other filings by this issuer (1)
More